Purchase Order 36C26024P0768
- Not listed
- On November 1, 2019, the Veterans Integrated Service Network 1 (VISN 1), a regional network within the Department of Veterans Affairs, awarded a purchase order valued at $470,781 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the procurement of radiopharmaceuticals. The contract, structured as a firm fixed-price purchase order with no set-aside designation, is scheduled for completion by December 31, 2025, and covers the supply and delivery of...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10), awarded a $75,228.11 firm fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on December 18, 2025, for the supply of nuclear medicine radiopharmaceuticals. The contract, which carries an ultimate completion date of December 17, 2028, represents a delivery order under a larger indefinite delivery vehicle established between the VA and Jubilant...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a delivery order valued at $521,738.46 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on March 5, 2026, with an ultimate completion date of March 4, 2027. This firm fixed-price delivery order, with no set-aside designation, procures radiopharmaceuticals for delivery to the Norcross, Georgia location. Jubilant Radiopharma, a for-profit small disadvantaged business...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), awarded a $94,000 firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for radiopharmaceuticals with a performance location in North Providence, Rhode Island. The contract was awarded on March 6, 2026, with an ultimate completion date of March 5, 2027, and does not carry a set-aside designation. Jubilant Radiopharma is a small disadvantaged...
- The Department of Veterans Affairs Veterans Health Administration awarded a $143,628.22 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for radiopharmaceuticals to support diagnostic imaging and treatment procedures at the Portland VA Medical Center. This order was not set aside for any socioeconomic program. Jubilant Radiopharma is a small disadvantaged business that has received over $10 million in federal contract awards...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a $120,197.85 firm fixed price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the supply of radiopharmaceutical products to support diagnostic imaging and cancer treatment procedures at the Portland VA Medical Center. Jubilant Radiopharma is a self-certified small disadvantaged business that has received multiple VA and Defense Health Agency contract awards,...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a $516,060.56 firm fixed-price delivery order by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs, on March 5, 2025. The contract, which is not set aside for small businesses despite the contractor's small disadvantaged business certification, calls for the supply of radiopharmaceuticals to support nuclear medicine operations at VA medical...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a delivery order valued at $382,001.07 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on March 1, 2025, for the supply of nuclear medicine imaging radio-therapeutic isotopes. The contract, which carries a firm fixed price structure with an ultimate completion date of February 28, 2026, was awarded without set-aside designation. Jubilant Radiopharma, a small...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a small disadvantaged business, to provide radiopharmaceuticals to the Portland VA Medical Center. The $127,189.00 contract supports diagnostic imaging and cancer treatment procedures at the VA facility. Jubilant Radiopharma holds multiple indefinite delivery, indefinite quantity (IDIQ) contracts...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a delivery order valued at $104,805.52 for radiopharmaceuticals by Veterans Integrated Service Network 6 (VISN 6), with an ultimate completion date of March 4, 2026. This firm fixed-price delivery order was issued without set-aside designation on March 5, 2024, and will be performed in Norcross, Georgia. The awardee is a for-profit small disadvantaged business that manufactures and distributes...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 20, awarded a $110,551.19 firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on July 1, 2024, for radiopharmaceuticals to support the Portland Veterans Affairs Medical Center. The contract, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance occurring at the vendor's facility in Norcross, Georgia. Jubilant Radiopharma is a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited that specializes in the manufacturing and distribution of radiopharmaceuticals and nuclear medicine products essential for diagnostic imaging and therapeutic applications. This purchase order represents a discrete delivery against Jubilant Radiopharma's broader relationship with the VA, where the company maintains multiple significant Indefinite Delivery Vehicles across various VA networks with potential values ranging from $420,000 to $39.8 million. The company supplies a comprehensive portfolio of specialized medical isotopes including Technetium-99m, Gallium-68 Dotatate, Iodine-123, and other radiopharmaceutical products used in positron emission tomography (PET) scans, cardiac imaging, and cancer treatment diagnostics. These products are critical to supporting nuclear medicine procedures and diagnostic capabilities at VA medical facilities nationwide, enabling the department to deliver specialized imaging and therapeutic services to the veteran population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($35k) | 12/15/25 | |
| P00001 | Other Administrative Action | $0 | 10/2/24 | |
| Not listed | Not listed | $145.4k | 6/28/24 |